Coronavirus and SARS-CoV-2

Coronavirus disease (COVID-19) is a new infection and virulent respiratory disease occurs when virus-containing particles expired by an infected person, either respiratory droplets or aerosols effectuated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an uncommon severe acute respiratory syndrome coronavirus. Although SARS-CoV-2 has a response for ACE2-expressing epithelial cells of the respiratory tract, patients with severe COVID-19 have symptoms of systemic hyper inflammation. The virus predominantly spreads between people through close contact and by means of respiratory droplets induced from coughs or sneezes and it mainly enters human cells by binding to the receptor angiotensin converting enzyme 2.

Most common symptoms are:

  • Fever
  • Dry cough
  • Tiredness

Related Conference of Coronavirus and SARS-CoV-2

August 16-16, 2021

3rd World Conference on Vaccine and Immunology

Dubai, UAE
August 27-28, 2021

5th International Conference on Emerging Infectious Diseases

Amsterdam, Netherlands
September 20-21, 2021

11th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa
October 12-13, 2021

International Conference on Vaccine and Vaccine research

Manila, Philippines
October 14-15, 2021

13th Annual Conference on Clinical Immunology

Cape Town, South Africa
November 04-05, 2021

9th World Summit on Immunology & Immunotherapy

Prague, Czech Republic
November 08-09, 2021

International Conference on Immunology Research

Las Vegas, USA
February 07-08, 2022

International Conference on Vaccine Research

Paris, France
March 21-22, 2022

36th International Conference on Immunology

Rome, Italy
March 21-22, 2022

15th Global Summit on Immunology and Cell Biology

Tokyo, Japan

Coronavirus and SARS-CoV-2 Conference Speakers

Recommended Sessions

Related Journals

Are you interested in